(Q37037941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

The medical management of the epilepsies in children: conceptual and practical considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author

Miquel Raspall-Chaure

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Brian G Neville

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Rod C Scott

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

57-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Two-year remission and subsequent relapse in children with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Cognitive and behavioral effects of nocturnal epileptiform discharges in children with benign childhood epilepsy with centrotemporal spikes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Staged approach to epilepsy management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The natural history of epilepsy: an epidemiological view.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Optimizing therapy of seizures in children and adolescents with developmental disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Reversible disability associated with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Early development of intractable epilepsy in children: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Some aspects of prognosis in the epilepsies: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Risk of recurrent seizures after two unprovoked seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Epileptic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Conversions between monotherapies in epilepsy: Expert consensus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Effectiveness of first antiepileptic drug.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Pharmacological overtreatment in epilepsy: mechanisms and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Epilepsy with myoclonic absences

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Current trends in antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A new social communication intervention for children with autism: pilot randomised controlled treatment study suggesting effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Impact of epilepsy characteristics and behavioral problems on school placement in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Sleep disorders, epilepsy, and autism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Overtreatment in epilepsy: adverse consequences and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Comprehensive care of the epilepsy patient--control, comorbidity, and cost

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The ideal characteristics of antiepileptic therapy: an overview of old and new AEDs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Current limitations of antiepileptic drug therapy: a conference review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The use of antiepileptic drugs--principles and practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The birth and evolution of the concept of Panayiotopoulos syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Treatment of children with simple febrile seizures: the AAP practice parameter. American Academy of Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Population study of benign rolandic epilepsy:: Is treatment needed?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Guidelines--are they useful?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Epilepsy: from consensus to daily practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Evidence-based epileptology, randomized controlled trials, and SANAD: a critical clinical view

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Old versus new antiepileptic drugs: the SANAD study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Old versus new antiepileptic drugs: the SANAD study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Options after the first antiepileptic drug has failed.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The management of refractory idiopathic epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Response to first drug trial predicts outcome in childhood temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Defining intractability: comparisons among published definitions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A follow-up study of intractable seizures in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

How long does it take for epilepsy to become intractable? A prospective investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Effects of rationalizing drug treatment of patients with epilepsy and mental retardation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A systematic review of the use of the ketogenic diet in childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Seizure reduction and quality of life improvements in people with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The impact of epilepsy surgery on quality of life in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Long-term psychosocial outcomes of anterior temporal lobectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Encephalopathy with electrical status epilepticus during slow sleep or ESES syndrome including the acquired aphasia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Reducing overtreatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Overtreatment in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Overtreatment in epilepsy: how it occurs and how it can be avoided

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Mono- or polypharmacotherapy in institutionalized epileptic children with severe mental retardation? A team approach for optimizing antiepileptic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Therapeutic intervention in mentally retarded adult epileptics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Reduction of two-drug therapy in intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Reduction of polypharmacy for epilepsy in an institution for the retarded

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Tolerability of antiseizure medications: implications for health outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Neuropsychological effects of epilepsy and antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Childhood epilepsy in relation to mental handicap and behavioural disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Cognitive side effects of antiepileptic drugs in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Idiosyncratic adverse reactions to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Valproic acid hepatic fatalities: a retrospective review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Predictors of Lamotrigine-associated rash

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Intelligence in childhood epilepsy syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Seizures and antiepileptic drugs: does exposure alter normal brain development?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Aggravation of epilepsy by anti-epileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Monitoring for adverse effects of antiepileptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Paediatric quality of life instruments: a review of the impact of the conceptual framework on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A review of subjective impact measures for use with children and adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Outcome assessment in epilepsy: comparative responsiveness of quality of life and psychosocial instruments.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Principles of health-related quality of life: assessment in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Asymptomatic children with epilepsy: little benefit from screening for anticonvulsant-induced liver, blood, or renal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Valproate-associated coagulopathies are frequent and variable in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A prospective randomised trial on the effect of monitoring plasma anticonvulsant levels in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Relapse following discontinuation of antiepileptic drugs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

A comparison between one and three years of treatment in uncomplicated childhood epilepsy: a prospective study. II. The EEG as predictor of outcome after withdrawal of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Four-year outcome after early withdrawal of antiepileptic drugs in childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Starting and stopping treatment for seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Discontinuing antiepileptic drugs in children with epilepsy: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The spectrum of benign infantile seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Juvenile myoclonic epilepsy: long-term response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Discontinuation of anticonvulsant therapy in children free of seizures for 1 year: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure-free patients: a review of current clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

Rapid versus slow withdrawal of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970324-1

7 January 2021

10.1016/S1474-4422(07)70324-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18093563%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference